Sharad Sharma, MD
Transplant Surgery · Huntsville, TXNPI 1831229152
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 35.7% of the total. Reporting peaked in 2020 at $2,015 and has fallen 81.3% since, to $377 in 2025.
Across 77 payments — averaging $56.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$2K
- Merit Medical Systems Inc$1K
- Medical Device Business Services, Inc.$981
- AstraZeneca$96
- Avenu Medical Inc.$91
- Stryker$84
- plus $339 from 8 others
What the payments were for
- Consulting fees$4009%
- Travel & lodging$1,70439%
- Food & beverage$2,23752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 47 | $1,551 |
| Merit Medical Systems Inc | 6 | $1,198 |
| Medical Device Business Services, Inc. | 6 | $981 |
| AstraZeneca | 1 | $96 |
| Avenu Medical Inc. | 2 | $91 |
| Stryker | 2 | $84 |
| Johnson & Johnson(2 entities) | 3 | $77 |
| Lemaitre Vascular, Inc. | 2 | $69 |
| Olympus America Inc. | 1 | $67 |
| Novartis | 2 | $42 |
| Medtronic | 2 | $28 |
| Venturemed Group, Inc. | 1 | $23 |
| Covidien LP | 1 | $20 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,341 in reported general payments places this provider in the 60th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 127 | $795 |
| Midodrine Hcl | 16 | $695 |
| Lactulose | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Huntsville
- Sridhar AllamMcAllen$392K
- Rafik GhobrialHouston$144K
- Goran KlintmalmDallas$88K
- Constance MobleyHouston$56K
- David HallHouston$43K
- Ahmed GaberHouston$35K
- Nhu Thao GalvanHouston$22K
- Alejandro MejiaDallas$20K
- Richard RuizDallas$16K
- Colleen JaySan Antonio$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.